MANILA, PHILIPPINES — August 16, 2026 — Bauertek Pharmaceutical Technologies, a proudly Filipino pharmaceutical innovation firm, has earned two Gold Medals and one Silver Medal — a total of three prestigious honors — at the Silicon Valley International Invention Festival (SVIIF) Awards Ceremony, held in California, USA. The event, themed “The Heartbeat of Invention and Innovation,” is one of the world’s leading gatherings of inventors, scientists, and innovators, organized in partnership with the International Inventors Federation (IIFIA), World Intellectual Property Organization (WIPO), and the United Inventors Association.
Three Awards for Filipino Innovation
Bauertek’s groundbreaking patented inventions each earned Gold or Silver Medals and official SVIIF Diplomas, recognizing their scientific merit, originality, and potential global impact:
– TRIHERBGI — A specialized formulation developed for the effective management and treatment of digestive tract disorders, offering a novel, plant-based therapeutic approach.
– JAMPERINE — A breakthrough formulation targeting pancreatic function, engineered to help activate the pancreas to naturally produce insulin, offering new hope in diabetes care.
– ProNitroLite or PNL— An innovative metabolic wellness solution designed to support healthy fat metabolism and energy utilization, with the core concept: “Turning Fat Into Fitness.”
The inventions are patented under the names of Inventors Richard Nixon Gomez and Rigel Gomez, whose research and development work represents years of rigorous scientific study and clinical refinement.
Bauertek’s booth prominently displayed the Philippine flag, standing as a symbol of national pride and reinforcing the country’s growing role in global pharmaceutical research and invention.
SVIIF judges evaluated thousands of entries from across the globe, assessing novelty, inventive step, utility, and societal impact. Bauertek’s haul of two Gold and two Silver awards underscores the world-class quality and originality of Filipino-led pharmaceutical innovation.
Moving forward, the company aims to advance clinical development, secure broader international intellectual property protection, and partner with global healthcare distributors to make these life-enhancing products available to patients worldwide — starting with communities across the Philippines.